Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 39, n° 2S2
pages 108-113 (août 1998)
Doi : 10.1016/S0190-9622(98)70457-8
Systemic treatment of neoplastic conditions with retinoids
 

Ming-Chu Hsu, PhD
Taiwan, ROC 
From the Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taiwan 


 At the time of the conference (May 2-4, 1997), Dr. Hsu was Research Director of Oncology at Hoffmann-La Roche in Nutley, New Jersey.
 Reprint requests: Ming-Chu Hsu, PhD, Director, Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, 128, Section II, Yen-Chiu-Yuan Road, Taipei 115, Taiwan, ROC.
 (J Am Acad Dermatol 1998;39:S108-13.)
 0190-9622/98/$5.00 + 0  16/0/91616


Top of the page

© 1998  American Academy of Dermatology, Inc. Published by Elsevier Masson SAS@@#104157@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@